| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Wu, Ting-Hui
|
|
2018
|
19 |
3 |
p. e361-e372
|
artikel
|
| 2 |
Cell Death, Inflammation, Tumor Burden, and Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response and Correlate With Tumor Volume and Proliferation Imaging
|
Salem, Ahmed
|
|
2018
|
19 |
3 |
p. 239-248.e7
|
artikel
|
| 3 |
Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy: A Systematic Review and Meta-Analysis
|
Hegi, Fiona
|
|
2018
|
19 |
3 |
p. 199-212
|
artikel
|
| 4 |
Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non–Small-cell Lung Cancer: A Phase I Study
|
Massabeau, Carole
|
|
2018
|
19 |
3 |
p. e277-e285
|
artikel
|
| 5 |
Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab
|
Park, Wungki
|
|
2018
|
19 |
3 |
p. 280-288.e4
|
artikel
|
| 6 |
Editorial Board
|
|
|
2018
|
19 |
3 |
p. A5
|
artikel
|
| 7 |
Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis
|
Sharma, Sonam
|
|
2018
|
19 |
3 |
p. 260-269.e3
|
artikel
|
| 8 |
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial
|
Ramalingam, Suresh S.
|
|
2018
|
19 |
3 |
p. 270-279.e3
|
artikel
|
| 9 |
Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non–small-cell Lung Cancer
|
Stoy, Sean P.
|
|
2018
|
19 |
3 |
p. 230-238.e2
|
artikel
|
| 10 |
Ground-Glass Component in Lung Adenocarcinoma and Better Survival
|
Tamura, Tomohiro
|
|
2018
|
19 |
3 |
p. e359
|
artikel
|
| 11 |
LAG-3 in Non–Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
|
Hald, Sigurd M.
|
|
2018
|
19 |
3 |
p. 249-259.e2
|
artikel
|
| 12 |
Pilot Study of the Safety and Efficacy of Dose Escalation in Stereotactic Body Radiotherapy for Peripheral Lung Tumors
|
Mitsuyoshi, Takamasa
|
|
2018
|
19 |
3 |
p. e287-e296
|
artikel
|
| 13 |
Radiologic–Pathologic Correlation of Solid Portions on Thin-section CT Images in Lung Adenocarcinoma: A Multicenter Study
|
Yanagawa, Masahiro
|
|
2018
|
19 |
3 |
p. e303-e312
|
artikel
|
| 14 |
Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non–Small-Cell Lung Cancer (RELAY): Phase Ib Results
|
Reck, Martin
|
|
2018
|
19 |
3 |
p. 213-220.e4
|
artikel
|
| 15 |
Real-world Efficacy and Safety of Nivolumab for Advanced Non–Small-cell Lung Cancer: A Retrospective Multicenter Analysis
|
Kobayashi, Keigo
|
|
2018
|
19 |
3 |
p. e349-e358
|
artikel
|
| 16 |
Safety and Efficacy of PD-1/PD-L1 Inhibitors in Treatment-Naive and Chemotherapy-Refractory Patients With Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
|
Khunger, Monica
|
|
2018
|
19 |
3 |
p. e335-e348
|
artikel
|
| 17 |
Sarcomatoid Carcinoma of the Lung: The Mayo Clinic Experience in 127 Patients
|
Maneenil, Kunlatida
|
|
2018
|
19 |
3 |
p. e323-e333
|
artikel
|
| 18 |
Table of Contents
|
|
|
2018
|
19 |
3 |
p. A7-A10
|
artikel
|
| 19 |
Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non–Small-Cell Lung Cancer: A Two-Institution Propensity Score–Matched Analysis
|
Ma, Sung Jun
|
|
2018
|
19 |
3 |
p. e297-e302
|
artikel
|
| 20 |
Use of SuperARMS EGFR Mutation Detection Kit to Detect EGFR in Plasma Cell-free DNA of Patients With Lung Adenocarcinoma
|
Cui, Shaohua
|
|
2018
|
19 |
3 |
p. e313-e322
|
artikel
|
| 21 |
Utility of Maximum Standard Uptake Value as a Predictor for Differentiating the Invasiveness of T1 Stage Pulmonary Adenocarcinoma
|
Fu, Lilan
|
|
2018
|
19 |
3 |
p. 221-229
|
artikel
|
Tijdschrift beschrijving